강효정 교수(약학대학 약학과)
o (1998) B.A., Korea University, Seoul, Korea
o (2000) M.A.,Korea University, Seoul, Korea
o (2024) Ph.D., Texas A&M University, College Station, TX, USA
o (2022.04~Present) Professor, Kyungpook National University, Daegu, Korea
o (2017.04~2022.03) Associated Professor, Kyungpook National University, Daegu, Korea
o (2011.03~2017.03) Assistant Professor, Kyungpook National University, Daegu, Korea
o (2007.08~2011.02) Postdoctoral Researcher, The Wistar Institute, Philadelphia, PA, USA
o (2005.01~2007.08) Postdoctoral Researcher, Texas A&M Health Science Center, College Station, TX, USA
o (200.01~2004.12) Research Assistant, Texas A&M University, College Station, TX, USA
0 Epstein-Barr virus pathogenesis and oncogenic mechanisms
0 Oncolytic virotherapy development
0 Coronavirus replication and gene expression
0 Epigenetic mechanisms in cancer and drug development
1) Epstein-Barr Virus (EBV) Pathogenesis and Oncogenic Mechanisms:
o Elucidating the molecular mechanisms underlying EBV-induced pathogenesis and oncogenesis.
o Investigating the role of epigenetic modifications, particularly DNA methylation, in EBV-associated cancers.
o Identifying and characterizing novel CTCF binding sites in the EBV genome and their impact on viral gene expression and host cell
transformation.
2) Oncolytic Virotherapy Development:
o Developing and evaluating oncolytic viruses based on adenovirus and HSV-1 platforms for cancer treatment.
o Targeting viral lytic genes and optimizing therapeutic efficacy and safety of oncolytic viruses.
3) Coronavirus Replication and Gene Expression:
o Investigating the molecular mechanisms of coronavirus replication, including the role of 5'UTR stem-loop structures.
o Understanding the regulation of subgenomic RNA production in coronaviruses.
4) Epigenetic Mechanisms in Cancer and Drug Development:
o Elucidating the role of epigenetic modifications, such as DNA methylation, in cancer development and progression.
o Developing novel therapeutic strategies Targeting epigenetic regulators for cancer treatment.
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):